NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: The Scott Partnership
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Novozymes Spotlights Innovative Solutions for Medical Devices, Drug Delivery and Formulation At CPhI - Novozymes Biopharma, part of Novozymes A/S, world leader in bioinnovation, will be highlighting its innovative sodium hyaluronate and recombinant human albumin products at CPhI Wordwide 2010
Novozymes Spotlights Innovative Solutions for Medical Devices, Drug Delivery and Formulation At CPhI

 

NewswireToday - /newswire/ - Nottingham, United Kingdom, 2010/09/09 - Novozymes Biopharma, part of Novozymes A/S, world leader in bioinnovation, will be highlighting its innovative sodium hyaluronate and recombinant human albumin products at CPhI Wordwide 2010.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

These solutions offer a range of unique advantages for medical devices, drug delivery and formulation and will be showcased, along with a live product demonstration area, at booth #6L2 at the Paris Nord Villepinte, October 5-7, in Paris, France.

Novozymes' novel sodium hyaluronate is 100% free of animal-derived raw materials and organic solvent remnants and offers a range of benefits including increased safety, batch-to-batch consistency and stability in large scale. The product can be used within the pharmaceutical sector for improved drug delivery as well as in medical device application areas including ophthalmology, wound healing and dermal fillers. Derived from Novozymes' proprietary yeast expression technology, Recombumin is the world's leading animal-free, commercially available recombinant human albumin. Offering the stabilizing benefits of albumin in a GMP compliant and regulatory package for medical devices, drug delivery and formulation, Recombumin ensures high performance and security of long term supply.

Peter Roshholm, vice president, Novozymes Biopharma comments: "Novozymes is delighted to be returning to CPhI following our success at the show over the past two years, winning Gold and Bronze innovation Awards in 2008 and 2009 respectively. This year the company will showcase its innovative biomanufacturing solutions which are helping customers to improve the efficiency of their processes. These proven solutions ensure improved consistency and a decreased regulatory burden while enabling the development of superior final products."

Novozymes will also be hosting a session entitled "Novozymes award winning cGMP sodium hyaluronate for medical device and drug delivery applications" during the show. The presentation is open to all delegates and will take place on October 6 at the CPhI Speaker's Corner located on the show floor.

To learn more about the company's solutions for drug delivery, formulation and medical devices, please visit Novozymes at booth #6L2 at CPhI Worldwide 2010.

About Novozymes
Novozymes (novozymes.com) is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources.

With over 700 products used in 130 countries, Novozymes' bioinnovations improve industrial performance and safeguard the world's resources by offering superior and sustainable solutions for tomorrow's ever-changing marketplace.

Novozymes' natural solutions enhance and promote everything from removing trans fats in cooking, to advancing biofuels to power the world tomorrow. Our never-ending exploration of nature's potential is evidenced by over 6,000 patents, showing what is possible when nature and technology join forces.

Our 5,000+ employees working in research, production and sales around the world are committed to shaping business today and our world tomorrow.

Contacts: Novozymes Biopharma - Sally Vernon, Customer Communications Manager.

Corporate Contacts:
Press and media:
Johan Melchior / T: +45 4446 0690 / M: +45 3077 0690
René Tronborg / T: +45 4446 2274 / M: +45 3077 2274
Paige Donnelly (USA) / T: +1 919 494 3209 / M: +1 919 218 4501

Investor relations:
Tobias Bjørklund / T: +45 4446 8682 / M: +45 3077 8682
Thomas Bomhoff (USA) / T: +1 919 494 3483 / M: +1 919 649 2565

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Novozymes Spotlights Innovative Solutions for Medical Devices, Drug Delivery and Formulation At CPhI

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Fiona Robinson - Scottpr.com 
+44(0)14 7753 9539 SYKE[.]novozymes.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Bruker Launches IconIR Nanoscale IR Spectroscopy Platform
Artificial Intelligence to Boost the Global Wound Care Market by 2026 with Minimal Intervention Solutions Finds Frost & Sullivan
Imec Signs Licensing Agreement with miDiagnostics to Commercialize its Patented Technology for Fast and Reliable COVID-19 Diagnosis
Withings Announces the FDA Clearance of ScanWatch its Most Medically Advanced Hybrid Smartwatch
Bruker Launches the Q4 POLO - Compact Spark-OES Metals Analyzer
Respiratory Health Management Market to Expedite Digital, Smart, and Portable Solutions Says Frost & Sullivan
Bruker Joins PANACEA Network to Broaden Access to NMR for European Chemistry Community
High-end Global Computed Tomography Purchases to Propel the High-end CT Segment Revenue Finds Frost & Sullivan
KRAIBURG TPE Introduces Ergonomically Designed Healthcare Equipment
Fujifilm Lauded by Frost & Sullivan for Disrupting the Operating Room Space with its Systems Integration Solution
BASF’s Irgastab® Enables LOTTE Chemical to Deliver High-clarity Medical Polypropylene for Syringes Used in COVID-19 Vaccinations
Withings and One Drop Partner to Bring Best-in-class Medical Devices to Multi-condition Employer Program
BIOTRONIK Applauded by Frost & Sullivan for its Disruptive Implantable Cardiac Monitoring Device, BIOMONITOR IIIm
Sensor Technologies for Pressure Injury Prevention Improve Outcomes and Operational Efficiency for Hospitals Finds Frost & Sullivan
New Bruker NMR Life Science Research Solutions Enable Functional Structural and Cellular Biology Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Mokuyobi

Visit  BizJobs.com





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)